COMP <GO>
CLB vs XOM // EV/EBITDA & P/E VALUATION
Core Laboratories Inc. (NYSE) VS. Exxon Mobil Corporation (NYSE) • 15-METRIC TALLY: CLB 5
— XOM 6
▲ EV/EBITDA & P/E VALUATION LEADER: CLB
LAST: $10.40 (-0.86%) • MKT CAP: $477.2M
valuation
8.6x
LAST: $183.29 (+0.70%) • MKT CAP: $753.67B
valuation
13.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLB VS. XOM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLB | XOM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.60% | 9.86% | +2.74 | CLB | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 8.6x | 13.9x | -5.27 | CLB | /valuation <GO> |
| Free Cash Flow Yield | 5.41% | 2.51% | +2.90 | CLB | /fcf-yield <GO> |
| Operating Margin | 10.70% | 10.96% | -0.26 | XOM | /operating-margins <GO> |
| Net Profit Margin | 5.60% | 7.57% | -1.97 | XOM | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | -4.40% | +4.90 | CLB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.39% | 2.20% | -1.81 | XOM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.65 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | CLB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.22% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.9 | 67.1 | -12.23 | XOM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.28 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.0x | 14.3x | +0.66 | XOM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $477.2M | $753.67B | -$753.20B | XOM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLB REV | XOM REV | CLB GROSS % | XOM GROSS % | CLB FCF | XOM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $526.5M | $332.24B | 20.7% | — | $25.8M | $23.61B |
| FY 2024 | $523.8M | $349.58B | 19.7% | — | $44.5M | $30.72B |
| FY 2023 | $509.8M | $344.58B | — | — | $24.8M | $33.45B |
| FY 2022 | — | $413.68B | — | — | — | $58.39B |
| FY 2021 | — | $285.64B | — | — | — | $36.05B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLB // BETA —
XOM // BETA 0.28